These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 15272270)

  • 21. Mitochondrial dysfunction in Parkinson's disease.
    Schapira AH
    Cell Death Differ; 2007 Jul; 14(7):1261-6. PubMed ID: 17464321
    [No Abstract]   [Full Text] [Related]  

  • 22. The paths to neurodegeneration in genetic Parkinson's disease.
    Abdel-Salam OM
    CNS Neurol Disord Drug Targets; 2014; 13(9):1485-512. PubMed ID: 25106632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic factors involved in the pathogenesis of Parkinson's disease.
    Lee FJ; Liu F
    Brain Res Rev; 2008 Aug; 58(2):354-64. PubMed ID: 18313759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.
    Xu J; Zhong N; Wang H; Elias JE; Kim CY; Woldman I; Pifl C; Gygi SP; Geula C; Yankner BA
    Hum Mol Genet; 2005 May; 14(9):1231-41. PubMed ID: 15790595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
    Lim KL; Lim TM
    IUBMB Life; 2003 Jun; 55(6):315-22. PubMed ID: 12938733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes.
    Macedo MG; Anar B; Bronner IF; Cannella M; Squitieri F; Bonifati V; Hoogeveen A; Heutink P; Rizzu P
    Hum Mol Genet; 2003 Nov; 12(21):2807-16. PubMed ID: 12952867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease and cancer: the unexplored connection.
    Garber K
    J Natl Cancer Inst; 2010 Mar; 102(6):371-4. PubMed ID: 20215596
    [No Abstract]   [Full Text] [Related]  

  • 30. Is there a pathogenic role for mitochondria in Parkinson's disease?
    Vives-Bauza C; de Vries RL; Tocilescu MA; Przedborski S
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S241-4. PubMed ID: 20083000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How do Parkin mutations result in neurodegeneration?
    Imai Y; Takahashi R
    Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing in Parkinson's disease.
    McInerney-Leo A; Hadley DW; Gwinn-Hardy K; Hardy J
    Mov Disord; 2005 Jan; 20(1):1-10. PubMed ID: 15503301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging pathways in genetic Parkinson's disease: autosomal-recessive genes in Parkinson's disease--a common pathway?
    Fitzgerald JC; Plun-Favreau H
    FEBS J; 2008 Dec; 275(23):5758-66. PubMed ID: 19021753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model.
    Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H
    Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathways to neurodegeneration.
    Bossy-Wetzel E; Schwarzenbacher R; Lipton SA
    Nat Med; 2004 Jul; 10 Suppl():S2-9. PubMed ID: 15272266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development in researches for familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2009 Nov; 49(11):882-4. PubMed ID: 20030237
    [No Abstract]   [Full Text] [Related]  

  • 38. Autosomal recessive mutations in the development of Parkinson's disease.
    Lopez G; Sidransky E
    Biomark Med; 2010 Oct; 4(5):713-21. PubMed ID: 20945983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics of Parkinson disease.
    Pankratz N; Foroud T
    NeuroRx; 2004 Apr; 1(2):235-42. PubMed ID: 15717024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous PINK1 mutations: a susceptibility factor for Parkinson disease?
    Djarmati A; Hedrich K; Svetel M; Lohnau T; Schwinger E; Romac S; Pramstaller PP; Kostić V; Klein C
    Mov Disord; 2006 Sep; 21(9):1526-30. PubMed ID: 16755580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.